Medical Device Regulation in Australia: Safe and Effective? by McGee, Richard G et al.
1 
 
"This is the peer reviewed version of the following article: [McGee RG, Webster AC, Rogerson TE, 
Craig JC. Medical device regulation in Australia: safe and effective? MJA. 2012;196(4):256-60], 
which has been published in final form at [DOI: 10.5694/mja11.11261]. This article may be used for 
non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived 
Versions."  
Title: Medical device regulation in Australia: safe and effective? 
Word count: Abstract: 249, Main text: 2482 Figures: 2 Tables: 2 
Short title: Medical device regulation in Australia 
 
2 
 
Abstract 
Objective: Medical devices are widely used to improve patient outcomes but may also be 
hazardous. Recent government reports have suggested reform of the Australian Therapeutic 
Goods Administration (TGA). We aimed to describe the frequency, characteristics and 
outcomes of reports of possible harms related to medical devices submitted to the TGA 
using data made publically available on the TGA website. 
Design and setting: A retrospective analysis of data made publically available on the TGA 
website from January 2000 to December 2011 conducted in January 2012.  
Main outcome measures: The number and nature of reports of medical device incidents, 
recalls and alerts.  
Results: Up to December 2011, 6812 medical device incidents were reported to the TGA, 
although there were several time-periods where data was unavailable. Device incidents 
were reported more frequently in later years, most often by device sponsors and often 
attributed to mechanical problems. 295 deaths and 2357 serious injuries have been related 
to device incidents, with serious injury highest in 2009 (n=597). Most device incidents were 
not investigated (47.5%) or after investigation, no further action was taken (25.0%). During 
the same time-period, there were 35 medical device recalls and 34 medical device alerts 
issued by the TGA, with no consistent increase over time. 
Conclusions: Despite TGA reform proposals, greater transparency is still needed. 
Unaddressed issues include patchy and conflicting data in the public domain and inexplicit 
rationale for the large proportions of uninvestigated reports.  To maintain public confidence 
in the national regulatory system these issues need to be resolved. 
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Introduction 
Medical devices are ubiquitous in healthcare and have the potential to create large-scale 
health gains, but also unintended harms through device failure. In the United States in 2006, 
medical devices were responsible for 2712 deaths.1 The recall of DePuy Orthopaedics’ 
(Warsaw, Indiana, USA) articular surface replacement hip prosthesis helped to highlight 
deficiencies in medical device regulation worldwide.2, 3 Subsequent investigations in the 
United States showed that most high-risk medical devices were being approved through 
processes not designed to assess safety or efficacy.4 Investigations into medical device 
regulatory processes in Europe were hampered by a lack of transparency and 
accountability.1  
Medical device regulation is a complex and evolving area and recently a range of relevant 
reports and reform proposals relevant to the Australian Therapeutic Goods Administration 
(TGA) have been put forward. A Health Technology Assessment (HTA) tabled by the 
Department of Health and Ageing in December 2009 addressed “the regulatory burden on 
business that results from HTA processes”.5 After a consultation period, the TGA responded 
to this report in September 2011 by setting out proposals to reclassify joint replacement 
implants, amend the manner in which devices are included on the Australian Register of 
Therapeutic Goods (ARTG) and to increase the level of device product information available 
on the TGA website.6 In July 2011, the Department of Health and Ageing released a review, 
which sought to improve the transparency of the TGA across a wide range of areas including 
market authorisation processes, post market monitoring and compliance, and improved 
stakeholder involvement in the TGA.7 Subsequently in November 2011, the Senate Standing 
Committees on Community Affairs released a report into the regulatory standards for the 
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approval of medical devices in Australia, which made reference to most of the previous 
reports.8 In addition, this report made further recommendations relating to the recalled 
DePuy Orthopaedics’ articular surface replacement hip prosthesis, inducements paid by 
device companies to clinicians, improved reporting of adverse events by clinicians and the 
importation of medical devices over the internet, amongst others.8 Finally, in December 
2011, the TGA issued a document outlining their proposed response to these reports, of 
which some changes related to medical devices.9  
We aimed to investigate the frequency, characteristics and outcomes of reports of possible 
harms related to medical devices, from the Australian perspective, using data made 
publically available on the TGA website.
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Methods 
Data sources 
We only used publicly available sources of data, that is, information provided by the ARTG 
(https://www.ebs.tga.gov.au/ebs/ANZTPAR/PublicWeb.nsf/cuDevices?OpenView) and 
information on medical device incidents provided by the TGA website 
(http://www.tga.gov.au/index.htm, accessed 24th January 2012).  We did not utilise 
information contained in medical device bulletins because they are not publicly accessible 
(only Australian health professionals currently working in a healthcare facility are allowed to 
subscribe after their application is approved by the TGA) and their use requires the 
permission of the TGA. Ethical approval was not required for this study as it made use of 
publicly available data. All data extraction was conducted independently by RGM and TER 
with consensus agreement. 
Number of medical devices 
The ARTG provides information on therapeutic goods that may be legally supplied in 
Australia. Each entry in the ARTG provides information on one or more medical device(s), 
with variants of a device occupying a single entry, for example, two different sized hip 
replacements may occupy the one entry. Each entry listed on the ARTG is classified by 
manufacturers and the TGA into risk categories based on a series of algorithms.10 For 
example, low risk devices include non-sterile dressings, low-medium risk devices include 
contact lenses, medium-high risk devices include infant incubators and high-risk devices 
include permanent pacemakers. We used the ARTG website to determine the number and 
type of entries listed, which we used as a proxy for the number of medical devices available 
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on the Australian market. Due to the design of the ARTG website with the potential for 
multiple devices within one entry, we were unable to count the true number of devices.   
Reports of medical device incidents 
If a problem occurs with a medical device, it may be reported to the TGA. The TGA website 
provides information on the frequency and characteristics of received medical device 
incident reports. We analysed all publicly available medical device incident data from 
January 2000 to December 2011 to determine the number, source, cause, and reported 
effect of medical device incidents.  
Response of TGA to reports of medical device incidents 
The TGA may decide not to investigate an incident if further investigation is deemed not 
necessary at that time, or after investigation they may decide that no further action is 
necessary. On the other hand, if a medical device needs to be removed from the Australian 
market for reasons relating to quality, efficacy or safety, the TGA will issue a device recall. If 
the TGA wish to provide information or recommendations about a device such as the 
outcome of an investigation, a medical device alert may be issued, which does not 
necessarily indicate that a product is unsafe. Using the TGA website, we analysed all publicly 
available data from January 2000 to December 2011 to determine the outcome of medical 
device incident investigations.
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Results 
Number of medical devices 
There were 36 635 entries listed on the ARTG. Most of these were low risk (17 780 or 
48.5%), 10 815 (29.5%) were registered as low-medium risk, 4 981 (13.6%) were registered 
as medium-high risk and 3 059 (8.3%) were registered as high-risk. From the available data, 
we were unable to determine how many entries were added per year or how many 
unsuccessful medical device applications had been made to the TGA.  
Reports of medical device incidents 
Medical device incident statistics were unavailable for the following periods: January 2000 
to October 2000, June 2002 to December 2002, June 2003 to December 2003, June 2004 to 
December 2004 and July 2009 to December 2011. In total 6812, medical device incidents 
were reported to the TGA over the past ten years and they have become more frequent 
over time, see Table 1. It is unknown how many reports refer to the same medical device, as 
these data were not provided.   
There were 295 reported deaths related to device incidents, 2357 incidents associated with 
serious injury, 1542 incidents associated with temporary injury and 2616 incidents 
associated with no injury, see Figure 1. The number of serious injuries was highest in 2009 
(n=597). Further information on what injuries were caused or how death occurred was 
unavailable on the website. The reported effect of device incidents was missing in two 
cases. 
Device incidents were often attributed more than one cause, as 7644 causes were reported 
for 6812 device incidents. While the cause of medical device incidents was often unknown, 
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the second most commonly reported cause ‘mechanical’ (13.0%, 993/7644), sharply 
increased towards the end of the sample period, representing 32.8% (316/962) of all reports 
in 2009, see Table 2. Medical device sponsors reported the most incidents (56.5%, 
3850/6812), see Table 2. The source of incident reports was missing in 10 cases. 
Response of TGA to reports of medical device incidents 
Device incidents were often attributed more than one outcome, as there were 7369 
outcomes for 6812 device incidents. Most incident reports were either not investigated 
(47.5%, 3502/7369) or after investigation, no further action was taken (25.0%, 1841/7369). 
The proportion of incident reports not investigated also increased in later years from 40.3% 
(62/154) in 2001, to 59.5% (575/967) in 2009. Only 3.3% (241/7369) of reports resulted in a 
device recall or hazard alert and 2.5% (187/7369) of reports in a safety alert being issued. A 
device fault was unconfirmed for 3.7% (272/7369) of cases, see Figure 2. It is unknown how 
many incident reports were assigned more than one outcome, as these data were not 
provided.  
There were 35 device recalls issued by the TGA, see Table 1. There was no consistent 
increase in the number of device recalls over time. Twelve of these recalls were considered 
high risk, as the device had the potential to be life threatening or cause a serious risk to 
health; for example ‘Four Seasons Glow’n’dark Condoms’ were recalled in 2003 because 
they failed to meet performance standards. Nineteen of these recalls were considered 
medium risk, as the device had the potential to cause illness or mistreatment for example 
‘INVACARE Action 2000 Wheelchairs’ were recalled in 2009 because of a fault that may have 
caused occupants to fall from their wheelchair and sustain injuries. Four of these recalls 
were considered low risk, as the device did not pose a significant hazard to health, for 
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example ‘Dejour tampons’ were recalled in 2003 for failing to meet mandatory absorbency 
requirements.  
Inconsistencies were found in the number of alerts issued by the TGA. An alphabetical list of 
all therapeutic alerts from January 2000 to December 2011 indicated there were 34 device 
related alerts. The same list sorted by date indicated there were 33 device alerts issued. We 
determined the true number of alerts by further comparing and crosschecking the complete 
lists sorted both alphabetically and by date. To determine the true number of alerts we 
made sure that each entry was only counted once. There were actually 34 unique device 
alerts issued, see Table 1. Device alerts did not consistently increase over time.  
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Discussion  
Based on publicly available data, over the past decade, 6812 medical device incidents 
associated with 295 deaths and 2357 serious injuries have been reported to the TGA. 
Reporting of medical device incidents has become more frequent, but most reports are not 
investigated (47.5%) or after investigation, no further action is taken (25.0%). A device fault 
was only unconfirmed in 3.7% of all cases. In comparison, between January 2000 and 
December 2011 there were only 35 medical device recalls and 34 medical device alerts 
issued by the TGA with no apparent increase over time. Furthermore, publicly available data 
was often incomplete, inconsistent and insufficient to understand the assessment of the 
safety and efficacy of medical devices, with no data available since 2009.  
Despite a series of reports urging transparency and reform, our investigations highlight a 
number of unaddressed issues. First, it is unclear why there are several periods where 
medical device incident data is unavailable, particularly as the number of serious injuries 
appeared to increase towards the end of 2009. In addition, the data provided on alerts was 
inconsistent. Second, it is unclear why so many incident reports were not investigated, while 
the proportion of unconfirmed device problems remained relatively constant. If these ‘false 
alarms’ remain constant, this implies that there may have been some validity to the incident 
report in the remaining cases although this cannot be determined because so many reports 
remain uninvestigated. Third, it is unclear what class of devices are being recalled. Current 
product recalls describe the level of risk presented by the device incident but not the device 
itself. Fourth, it is unclear why reports of medical device incidents are consistently 
increasing while device recalls are not. In total, 295 deaths related to device incidents were 
reported yet during a longer observational period, there were only 12 ‘high risk’ medical 
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device recalls. Increasing reports may reflect an increased awareness of the need to report 
all adverse events amongst the community for example, through the establishment of the 
National Joint Replacement Registry. It may also reflect increased adherence of companies 
to their legal obligations to report all adverse events, under sections 41MP and 41MPA of 
the Therapeutic Goods Act 1989.11 
On the other hand, as the TGA website is updated and other proposals are implemented, 
some issues are likely to be resolved. For example, the TGA have now proposed a plan of 
action to reform the way in which medical devices are included in the ARTG.9 From July 
2012, all ARTG entries for medical devices will need to include product name details. This 
will facilitate the generation of a list of all the medical devices available on the Australian 
market. In addition, there are proposals to provide greater levels of device product 
information on the TGA website.9  
While we have chosen to analyse data publicly available from the TGA website, this has led 
to a number of limitations. The data on medical device recalls, alerts and notifications, is 
provided at a summary level and so more advanced statistical analysis is not possible 
because data on individual devices is not provided. We were unable to determine if the rise 
in medical device incident reports was a random variation or the beginning of an increasing 
trend because of the lack of up to date data. In addition, we have not examined medical 
device bulletins or asked the TGA to provide further information. This is because we wanted 
to maintain the perspective of the average healthcare worker or informed consumer 
attempting to assess the safety and efficacy of a medical device. Finally, we could not locate 
data on the number of voluntary recalls issued by device manufacturers or the number of 
people affected by a recall because this data was not made public by the TGA.  
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Clearly, the demands being placed on the TGA are changing over time and the TGA are 
responding to these changes. While our primary concerns centre around the transparency 
of available data, the various government reports and TGA proposals have sometimes 
focussed on other important but different issues, for example the reclassification of 
prosthetic devices. None of the reports released to date or the reforms proposed by the 
TGA address the issues we have raised, namely missing and conflicting data, the increasing 
proportion of uninvestigated reports and a lack of information about the type of medical 
devices being recalled. The Senate Standing Committees on Community Affairs report only 
reference to transparency is the recommendation that “the Government implements the 
recommendations of the Therapeutic Goods Administration Transparency Review in a 
timely manner”.  Of the 21 recommendations contained in the Department of Health and 
Ageing review on the transparency of the TGA, none specifically mentions medical devices 
and none address the issues raised in this paper. Nevertheless, the TGA’s recently released 
blueprint for reform does contain some constructive proposals for example including more 
information about individual medical devices on the TGA website. These efforts will go some 
way towards increasing transparency and allow the public access to information to help 
them make informed decisions about the safety and effectiveness of any given device. 
In conclusion, medical devices are widely used to improve patient outcomes, but based on 
publicly available data from the TGA it is difficult to make informed decisions about the 
safety of any given device. Although recent government reports and reform proposals have 
gone some way towards improving the regulation of medical devices and the accountability 
of the TGA, greater transparency is still needed. Given the large number of reported deaths 
and serious injuries reportedly caused by device failures, this remains an issue of serious 
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concern and further change is needed, so that public confidence in the regulatory system 
can be maintained. 
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Figure legends 
Figure 1: Reported effect of medical device incidents submitted to the TGA, as of January 
2012  
Figure 2: Outcomes of TGA investigations  
1Not investigated: Every report receives a risk analysis and is discussed by a panel of 
technical and clinical professionals. In the case of reports that are "Not Investigated" the 
panel has made a decision that further investigation of the particular event is not necessary 
at that time. 
2Other: Includes safety alerts, compliance testing, bulletin articles, referral to Good 
Manufacturing Practice, company warnings and surveillance.
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Figures 
 
Figure 1: Reported effect of medical device incidents submitted to the TGA, as of January 
2012 
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Figure 2: Outcomes of TGA investigations  
1Not investigated: Every report receives a risk analysis and is discussed by a panel of 
technical and clinical professionals. In the case of reports that are "Not Investigated" the 
panel has made a decision that further investigation of the particular event is not necessary 
at that time. 
2Other: Includes safety alerts, compliance testing, bulletin articles, referral to Good 
Manufacturing Practice, company warnings and surveillance.
17 
 
Tables 
Table 1: Number of medical device recalls, alerts and incident reports  
* Data incomplete or missing for these years 
†Australian Register of Therapeutic Goods
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
All device recalls 0 1 1 4 0 0 5 1 9 1 2 5 
All device alerts 0 1 0 0 0 1 0 0 8 2 5 8 
Reports of 
medical device 
incidents 
138* 585 358* 327* 422* 672 939 1129 1316 926* -* -* 
Devices listed 
on ARTG† - - - - - - - - - - - 36 635 
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Table 2: The 10 most common sources of and reported causes of incident reports  
* Data incomplete or missing for these years 
 
 
 
 
 2000* 2001 
2002
* 
2003
* 
2004
* 
2005 2006 2007 2008 
2009
* 
2010
* 
2011* 
Totals 
10 most common sources of incident reports 
Sponsor 44 149 94 93 183 322 515 771 979 700 - - 3850 
Nurse 22 87 52 32 30 71 62 79 79 65 - - 579 
Hospital 
supply 
service 
13 79 53 26 48 46 54 67 52 11 - - 449 
Specialist 9 48 22 30 30 29 29 54 33 25 - - 309 
Biomedical 
engineer 
6 35 27 17 12 27 41 34 39 25 - - 263 
Blood bank 12 64 15 45 28 17 22 17 7 0 - - 227 
Medical 
administrator 
5 22 28 14 6 28 33 27 45 5 - - 213 
Overseas 
advice 
5 30 12 11 27 52 44 5 6 1 - - 193 
Patient/User 6 8 4 0 0 0 14 35 17 17 - - 101 
Other 16 63 51 56 57 63 85 78 93 56 - - 618 
              
10 most common causes of device incidents 
Unknown 25 96 37 42 64 155 251 366 269 118 - - 1423 
Mechanical 4 25 20 23 37 37 50 102 379 316 - - 993 
Not device 
related 
20 73 42 30 61 92 122 143 186 74 - - 843 
Component 
failure 
26 123 77 59 89 115 114 55 54 43 - - 755 
Electrical 8 44 17 8 10 26 9 56 138 166 - - 482 
Manufacture 12 59 32 27 21 53 70 67 77 17 - - 435 
Material/ 
Formulation 
deficiency 
16 80 51 57 38 34 36 38 48 33 - - 431 
Design 2 37 23 22 21 55 57 66 48 34 - - 365 
Wear/ 
Deterioration 
6 20 15 6 13 22 35 55 39 15 - - 226 
Other 60 197 173 123 124 153 282 267 166 146 - - 1691 
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